Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.7500
+0.5800 (341.18%)
Nov 26, 2025, 4:00 PM EST
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $1.12 million as of November 28, 2025. Its market cap has decreased by -88.84% in one year.
Market Cap
1.12M
Enterprise Value
18.18M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 1.12M, an increase of 341.46%. That is a compound annual growth rate of 10.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 4.93M | -49.88% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | 108.70M | 44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 566.42M |
| Glass House Brands | 486.37M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.51M |
| Silence Therapeutics | 323.08M |
| Nika Pharmaceuticals | 259.96M |